|Bid||38.650 x 0|
|Ask||38.700 x 0|
|Day's Range||38.550 - 39.300|
|52 Week Range||24.900 - 50.150|
|Beta (3Y Monthly)||1.07|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||1.41 (2.45%)|
|1y Target Est||44.58|
U.S. private equity firm Blackstone Group LP has signed a deal to invest $400 million in Hong Kong-listed YiChang HEC ChangJiang Pharmaceutical Co. via convertible bonds, HEC said Wednesday. The H share convertible bonds will bear an interest rate of 3 percent per annum if issued, at an initial conversion price of HK$38 per share, HEC Pharma said in a stock filing on Tuesday night. The drugmaker, based in Yichang in central China's Hubei province, is planning to use the funds to acquire drugs and other pharmaceutical products, it said.
July 3 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co Ltd: * NOTIFIED BY GUANGDONG HEC THAT, GUANGDONG HEC RECEIVED APPROVAL OF PROPOSED TRANSFER FROM CSRC ON 3 JULY 2018 * UPDATES ON PROPOSED TRANSFER ...
June 6 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co Ltd: * REFERS TO PROPOSED TRANSFER OF ENTIRE STAKE IN CO HELD BY HEC PHARM CO LTD TO GUANGDONG HEC TECHNOLOGY HOLDING * NOTIFIED THAT GUANGDONG ...
Today I will be providing a simple run-through of the discounted cash flows (DCF) method to estimate the attractiveness of YiChang HEC ChangJiang Pharmaceutical Co Ltd. (SEHK:1558) as an investmentRead More...